Table 2 Gasometric variables and serum renal biomarkers
From: Alactic base excess predicts the use of renal replacement therapy in patients with septic shock
Variable | Renal replacement therapy | ||
|---|---|---|---|
Total n = 164 | Yes n = 68 | No n = 96 | |
pH | 7.3 (7.2–7.4) | 7.3 (7.2–7.3) | 7.3 (7.2–7.4) |
PaO2/FiO2, mmHg (IQR) | 96.5 (75.0–137.5) | 100 (80–147.5) | 93.5 (71–125) |
PaCO2, mmHg (IQR) | 37.2 (35.6–38.7) | 33.5 (32–36) | 37 (36–41)* |
SBE, mmol/L (SD) | − 8.38 (± 6.44) | − 10.79 (± 6.03) * | − 6.67 (± 6.19) * |
HCO3−, mmol/L (SD) | 18.07 (± 5.02) | 15.83 (± 4.07) * | 19.66 (± 5.04) * |
Lactate mmol/L (IQR) | 3.2 (1.95–4.5) | 4.0 (2.8–5.9) * | 2.6 (1.7–3.8) * |
ABE, mmol/L (IQR) | − 4.2 (− 8.25 to − 1.35) | − 6.0 (− 9.95 to − 2.55)* | − 3.0 (− 5.05 to − 0.60)* |
AG, mEq/L (IQR) | 14.5 (11.7–17.5) | 15.3 (12.4–18.65)* | 13.85 (10.25–16.75)* |
Na–Cl, mEq/L (IQR) | 32 (30–35) | 31 (28.5–34.5)* | 33 (31–36)* |
SCr, mg/dL (IQR) | 2.05 (1.15–3.30) | 3.0 (2.10–5.35)* | 1.55 (0.90–2.65)* |
Urea, mg/dL (IQR) | 80 (50–126) | 116.4 (80–165)* | 61.5 (39–94)* |